In my experience capital raisings rarely occur prior to good news about to be announced, rather, they are usually opportunistic. Why would you raise capital if FDA approval was 'imminent' (to quote a common word used by management). Whilst this thread has some very competent posters I think some are running away with their enthusiasm rather than addressing some potentially serious issues raised by the previous poster. I'm staying sidelined for the present.
In my experience capital raisings rarely occur prior to good...
-
- There are more pages in this discussion • 743 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
